Cohort View enables associating mutation or expression data with patient outcomes.

(A) Genomic alterations affecting MYB in T-ALL, including amplification (red bars), coding mutation (x marks), truncating fusions (circles), and intergenic translocations leading to enhancer hijacking (TCRB, T-cell receptor beta locus).

(B) Kaplan-Meier plot of event-free survival of T-ALL patients, stratified by presence of MYB alteration in (A).